Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.
Introduced
Jan 8, 2025
Last Action
Jan 12, 2026
Session
NY 2025-2026
Sponsors
1 primary · 15 co
PASSED ASSEMBLY
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
DELIVERED TO SENATE
ORDERED TO THIRD READING CAL.9
DIED IN SENATE
RETURNED TO ASSEMBLY
PASSED ASSEMBLY
REPORTED REFERRED TO RULES
REPORTED
RULES REPORT CAL.705
ORDERED TO THIRD READING RULES CAL.705
DELIVERED TO SENATE
REPORTED REFERRED TO WAYS AND MEANS
PRINT NUMBER 265A
AMEND AND RECOMMIT TO ALCOHOLISM AND DRUG ABUSE
REFERRED TO ALCOHOLISM AND DRUG ABUSE
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
Michael Novakhov
Scott H. Bendett
Albert A. Stirpe
Steven Otis